56 computer-programmer-"https:"-"Inserm" "https:" "https:" "https:" "https:" "Dr" "P" research jobs at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
) Application Deadline 12 Feb 2026 - 00:00 (UTC) Country United Kingdom Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is
-
-intensive Universities (https://www.southampton.ac.uk/ ). We have an international reputation for research, teaching and enterprise activities. The job This is a part time (0.6 FTE) fixed appointment for a
-
Growth of Functional 1D and 2D Metal Dichalcogenide Semiconductors) Programme Grant recently announced by the UK Engineering and Physical Sciences Research Council (EPSRC). EXPRESS is a large (£10M
-
) Country United Kingdom Application Deadline 6 Feb 2026 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme
-
The Faculty of Medicine Genomic Informatics Group invites applications for a 3-year full time fixed-term postdoctoral position of Research Fellow or Senior Research Fellow in Genomic Informatics to
-
on Smart Fibre-Optic High-Power Photonics (HiPPo). The HiPPo programme (https://www.hippo-laser.co.uk/ ) is focused on understanding how to control the properties of fibre lasers, to go beyond the “fixed
-
of Electronics and Computer Science at the University of Southampton as part of the group of Prof. Kees de Groot and Dr Ruomeng Huang. This postdoctoral fellowship is part of the EXPRESS (Exploiting Single Source
-
We are delighted to welcome applications for a Research Fellow post within the ESRC Connecting Generations programme to examine intergenerational flows of support in later life and the increased
-
5 Feb 2026 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position
-
postdoctoral scientist to work on our Blood Cancer UK-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid leukaemia (AML). This three-year project will harness cytotoxic